corticosteroid
→
CapableOf
→
reduce inflammation
|
0.72
|
|
prednisone
→
IsA
→
corticosteroid
|
0.71
|
|
corticosteroid
→
CapableOf
→
reduce swelling
|
0.69
|
|
applied corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
absorbed in sufficient amounts
|
0.68
|
|
inhaled corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
recommended for the treatment of asthma
|
0.68
|
|
inhaled corticosteroid
(subgroup of
corticosteroid)
→
Causes
→
reduction
|
0.68
|
|
intranasal corticosteroid
(subgroup of
corticosteroid)
→
Causes
→
reduction
|
0.68
|
|
synthetic corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
mimic the action of cortisol
|
0.68
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
absorbed
|
0.68
|
|
corticosteroid
→
CapableOf
→
increase calcium excretion
|
0.67
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
likely to occur
|
0.67
|
|
corticosteroid
→
ReceivesAction
→
prescribed
|
0.66
|
|
corticosteroid
→
ReceivesAction
→
used in patient
|
0.62
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
minimal
|
0.61
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
mild
|
0.59
|
|
corticosteroid
→
ReceivesAction
→
used to treat inflammatory arthritis
|
0.59
|
|
administered corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
appear in human milk
|
0.59
|
|
administered corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
suppress growth
|
0.59
|
|
administered corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
interfere with endogenous corticosteroid production
|
0.59
|
|
systemic corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
withdrawn
|
0.59
|
|
corticosteroid
→
ReceivesAction
→
used to treat asthma
|
0.58
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
temporary
|
0.58
|
|
administered corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
cause other untoward effects
|
0.57
|
|
corticosteroid
→
IsA
→
hormone
|
0.57
|
|
corticosteroid
→
ReceivesAction
→
taken by mouth
|
0.55
|
|
corticosteroid
→
CapableOf
→
reduce pain
|
0.55
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
unknown
|
0.55
|
|
corticosteroid
→
UsedFor
→
the management of the disease
|
0.55
|
|
corticosteroid
→
CapableOf
→
suppress inflammation
|
0.54
|
|
corticosteroid
→
ReceivesAction
→
employed
|
0.54
|
|
corticosteroid
→
ReceivesAction
→
produced by adrenal glands
|
0.54
|
|
corticosteroid
→
CapableOf
→
treat inflammation
|
0.53
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
rare
|
0.51
|
|
corticosteroid
→
CapableOf
→
relieve pain
|
0.50
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
variable
|
0.50
|
|
corticosteroid
→
HasProperty
→
effective
|
0.50
|
|
corticosteroid
→
ReceivesAction
→
used with caution
|
0.50
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
balanced with potential benefits
|
0.49
|
|
corticosteroid
→
CapableOf
→
suppress immune system
|
0.48
|
|
corticosteroid
→
ReceivesAction
→
indicated in patient
|
0.48
|
|
corticosteroid
→
ReceivesAction
→
reduced
|
0.47
|
|
corticosteroid
→
ReceivesAction
→
secreted in breast milk
|
0.47
|
|
corticosteroid
→
CapableOf
→
provide immediate, temporary relief
|
0.46
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
reversible
|
0.46
|
|
corticosteroid
→
ReceivesAction
→
administered to rabbit
|
0.46
|
|
corticosteroid
→
ReceivesAction
→
used in combination
|
0.45
|
|
corticosteroid
→
ReceivesAction
→
referred as cortisone
|
0.45
|
|
corticosteroid
→
ReceivesAction
→
initiated
|
0.45
|
|
corticosteroid
→
ReceivesAction
→
injected
|
0.44
|
|
corticosteroid
→
HasProperty
→
essential
|
0.44
|
|
corticosteroid
→
CapableOf
→
treat rheumatoid arthritis
|
0.44
|
|
corticosteroid
→
ReceivesAction
→
taken as pill
|
0.44
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
monitored
|
0.43
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
avoided
|
0.43
|
|
systemic corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
used to control acute exacerbations
|
0.43
|
|
systemic corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
treat severe persistent asthma
|
0.43
|
|
corticosteroid
→
ReceivesAction
→
shown to be teratogenic
|
0.43
|
|
corticosteroid
→
ReceivesAction
→
discontinued
|
0.42
|
|
corticosteroid
→
ReceivesAction
→
metabolized in the liver
|
0.42
|
|
corticosteroid
→
HasA
→
effect
|
0.42
|
|
corticosteroid
→
CapableOf
→
mask some signs of infection
|
0.42
|
|
corticosteroid
→
ReceivesAction
→
excreted by kidney
|
0.42
|
|
corticosteroid
→
CapableOf
→
boost immune system
|
0.42
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
upset
|
0.41
|
|
corticosteroid
→
CapableOf
→
stimulate hepatic glucose production
|
0.41
|
|
corticosteroid
→
CapableOf
→
inhibit peripheral glucose uptake
|
0.41
|
|
corticosteroid
→
CapableOf
→
produce insulin resistance
|
0.41
|
|
corticosteroid
→
HasProperty
→
useful
|
0.40
|
|
corticosteroid
→
ReceivesAction
→
injected into the wrist
|
0.40
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
handled through pharmacokinetic pathways
|
0.40
|
|
corticosteroid
→
ReceivesAction
→
combined with azathioprine
|
0.40
|
|
corticosteroid
→
ReceivesAction
→
injected into affected joint
|
0.40
|
|
effect
(aspect of
corticosteroid)
→
CapableOf
→
remained controversial
|
0.40
|
|
corticosteroid
→
ReceivesAction
→
applied to the skin
|
0.39
|
|
corticosteroid
→
HasA
→
potential
|
0.39
|
|
corticosteroid
→
CapableOf
→
improve survival
|
0.39
|
|
corticosteroid
→
CapableOf
→
reduce mortality
|
0.39
|
|
corticosteroid
→
CapableOf
→
relieve symptom
|
0.39
|
|
corticosteroid
→
CapableOf
→
potentiate the replication of some organisms
|
0.39
|
|
corticosteroid
→
ReceivesAction
→
stopped
|
0.39
|
|
corticosteroid
→
ReceivesAction
→
produced by the body
|
0.39
|
|
corticosteroid
→
ReceivesAction
→
administered to dog
|
0.38
|
|
corticosteroid
→
Causes
→
weight gain
|
0.38
|
|
corticosteroid
→
ReceivesAction
→
used to treat allergy
|
0.38
|
|
corticosteroid
→
ReceivesAction
→
detected in human milk
|
0.38
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
administered to a nursing woman
|
0.37
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
applied to affected area
|
0.37
|
|
corticosteroid
→
HasA
→
serious side effects
|
0.37
|
|
effect
(aspect of
corticosteroid)
→
CapableOf
→
occur
|
0.37
|
|
ointment
→
HasA
→
corticosteroid
|
0.36
|
|
corticosteroid
→
ReceivesAction
→
prescribed in dose
|
0.35
|
|
corticosteroid
→
CapableOf
→
reduce irritation
|
0.35
|
|
systemic corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
mask elevated temperature
|
0.35
|
|
corticosteroid
→
ReceivesAction
→
continued throughout subsequent treatment
|
0.35
|
|
cortisone
→
IsA
→
corticosteroid
|
0.34
|
|
corticosteroid
→
CapableOf
→
come in both a pill
|
0.34
|
|
corticosteroid
→
CapableOf
→
inhibit release of inflammatory mediators
|
0.34
|
|
corticosteroid
→
CapableOf
→
reduce allergic reactions
|
0.34
|
|
corticosteroid
→
IsA
→
strong anti-inflammatory hormones
|
0.34
|
|
corticosteroid
→
HasProperty
→
absent
|
0.34
|
|
corticosteroid
→
CapableOf
→
induce first stage of parturition
|
0.34
|
|
corticosteroid
→
Causes
→
high blood pressure
|
0.34
|
|
corticosteroid
→
HasProperty
→
ineffective
|
0.34
|
|
corticosteroid
→
ReceivesAction
→
used in conjunction
|
0.34
|
|
corticosteroid
→
HasSubevent
→
increased incidence of congenital abnormalities
|
0.32
|
|
corticosteroid
→
HasSubevent
→
cleft
|
0.32
|
|
corticosteroid
→
CapableOf
→
increase blood glucose concentrations
|
0.32
|
|
corticosteroid
→
Causes
→
peptic ulceration
|
0.32
|
|
corticosteroid
→
CapableOf
→
shorten the severity of the relapse
|
0.32
|
|
corticosteroid
→
ReceivesAction
→
involved in the stress response
|
0.32
|
|
corticosteroid
→
ReceivesAction
→
inhaled
|
0.32
|
|
corticosteroid
→
CapableOf
→
increase the response warfarin
|
0.32
|
|
corticosteroid
→
CapableOf
→
enhance existing infection
|
0.32
|
|
corticosteroid
→
CapableOf
→
retain placenta
|
0.32
|
|
corticosteroid
→
ReceivesAction
→
administered for prolonged periods
|
0.32
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
discontinued
|
0.31
|
|
corticosteroid
→
CapableOf
→
range to frank psychotic manifestations
|
0.31
|
|
corticosteroid
→
HasProperty
→
safe
|
0.31
|
|
corticosteroid
→
Causes
→
diabetes
|
0.31
|
|
corticosteroid
→
CapableOf
→
affect ultimate outcome
|
0.30
|
|
corticosteroid
→
CapableOf
→
affect natural history of the disease
|
0.30
|
|
corticosteroid
→
ReceivesAction
→
administered with potassium-depleting agents
|
0.30
|
|
corticosteroid
→
AtLocation
→
the body
|
0.30
|
|
effect
(aspect of
corticosteroid)
→
CapableOf
→
vary
|
0.30
|
|
effect
(aspect of
corticosteroid)
→
CapableOf
→
use the best level of evidence
|
0.30
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
more pronounced
|
0.30
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
share anti
|
0.30
|
|
corticosteroid
→
ReceivesAction
→
avoided
|
0.30
|
|
corticosteroid
→
Causes
→
sodium
|
0.29
|
|
corticosteroid
→
Causes
→
cataract
|
0.29
|
|
corticosteroid
→
Causes
→
poor wound healing
|
0.29
|
|
corticosteroid
→
HasProperty
→
oral
|
0.29
|
|
corticosteroid
→
Causes
→
osteoporosis
|
0.28
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
serious
|
0.28
|
|
corticosteroid
→
ReceivesAction
→
referred by shortened term
|
0.28
|
|
corticosteroid
→
ReceivesAction
→
used to treat autoimmune diseases
|
0.28
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
more likely
|
0.28
|
|
corticosteroid
→
HasProperty
→
carcinogenic
|
0.28
|
|
corticosteroid
→
CapableOf
→
acquire pneumonia
|
0.28
|
|
corticosteroid
→
CapableOf
→
reduce itching
|
0.28
|
|
corticosteroid
→
CapableOf
→
reduce antiseptic or antibiotic ointments
|
0.28
|
|
corticosteroid
→
CapableOf
→
reduce mean time
|
0.28
|
|
corticosteroid
→
CapableOf
→
reduce symptoms of croup
|
0.28
|
|
corticosteroid
→
ReceivesAction
→
combined with cyclophosphamide
|
0.28
|
|
corticosteroid
→
HasSubevent
→
deformed forelegs
|
0.28
|
|
corticosteroid
→
HasSubevent
→
phocomelia
|
0.28
|
|
corticosteroid
→
HasSubevent
→
anasarca
|
0.28
|
|
corticosteroid
→
ReceivesAction
→
used in young animals
|
0.28
|
|
corticosteroid
→
CapableOf
→
improve lung function
|
0.28
|
|
corticosteroid
→
Causes
→
thinning of bones
|
0.28
|
|
corticosteroid
→
CapableOf
→
increase susceptibility
|
0.28
|
|
corticosteroid
→
CapableOf
→
cause
|
0.28
|
|
corticosteroid
→
CapableOf
→
retain metritis
|
0.26
|
|
corticosteroid
→
ReceivesAction
→
administered at low dosage levels
|
0.26
|
|
corticosteroid
→
CapableOf
→
produce fetal resorptions
|
0.26
|
|
corticosteroid
→
CapableOf
→
produce specific abnormality
|
0.26
|
|
corticosteroid
→
Causes
→
ulcer
|
0.26
|
|
corticosteroid
→
CapableOf
→
suppress growth
|
0.26
|
|
corticosteroid
→
CapableOf
→
improve function
|
0.26
|
|
systemic corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
caused deposition of calcium
|
0.26
|
|
corticosteroid
→
HasProperty
→
potent
|
0.25
|
|
corticosteroid
→
CapableOf
→
weaken bone
|
0.25
|
|
corticosteroid
→
Causes
→
water retention
|
0.25
|
|
corticosteroid
→
CapableOf
→
reduce joint inflammation
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
used in extensive alopecia areata
|
0.25
|
|
corticosteroid
→
CapableOf
→
impair fertility
|
0.25
|
|
corticosteroid
→
CapableOf
→
decrease potassium levels
|
0.25
|
|
corticosteroid
→
CapableOf
→
inhibit the oxidative burst
|
0.25
|
|
corticosteroid
→
CapableOf
→
mask infection
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
used in the presence of bacterial infections
|
0.25
|
|
corticosteroid
→
CapableOf
→
swell in different parts of the body
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
involved in carbohydrate metabolism
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
involved in protein catabolism
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
involved in blood electrolyte levels
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
involved in behavior
|
0.25
|
|
corticosteroid
→
CapableOf
→
mask elevated temperature
|
0.25
|
|
corticosteroid
→
CapableOf
→
calm inflammation
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
grouped into four classes
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
used to replace steroid
|
0.25
|
|
corticosteroid
→
CapableOf
→
fight white blood cells
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
initiated for grade
|
0.25
|
|
corticosteroid
→
CapableOf
→
reduce redness
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
used in ms
|
0.25
|
|
corticosteroid
→
CapableOf
→
shrink nasal polyps
|
0.25
|
|
corticosteroid
→
CapableOf
→
prevent blindness
|
0.25
|
|
corticosteroid
→
CapableOf
→
reduce pressure
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
consistent
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
encountered with long-term oral use
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
possible
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
controversial
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
kept in mind
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
CapableOf
→
depend on the dose
|
0.25
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
reduced
|
0.25
|
|
lotion
→
HasA
→
corticosteroid
|
0.25
|
|
corticosteroid
→
ReceivesAction
→
used in pregnancy
|
0.23
|
|
corticosteroid
→
CapableOf
→
contribute to bone loss
|
0.23
|
|
corticosteroid
→
CapableOf
→
resemble cortisol
|
0.23
|
|
corticosteroid
→
ReceivesAction
→
administered to the mother
|
0.22
|
|
corticosteroid
→
CapableOf
→
improve muscle strength
|
0.22
|
|
corticosteroid
→
CapableOf
→
decrease ability
|
0.22
|
|
corticosteroid
→
Causes
→
hypokalaemia
|
0.22
|
|
corticosteroid
→
CapableOf
→
reactivate dormant infections
|
0.22
|
|
corticosteroid
→
CapableOf
→
shorten survival
|
0.22
|
|
corticosteroid
→
CapableOf
→
affect the nitroblue-tetrazolium test
|
0.19
|
|
corticosteroid
→
HasProperty
→
inexpensive
|
0.19
|
|
corticosteroid
→
Causes
→
growth retardation
|
0.19
|
|
corticosteroid
→
CapableOf
→
interfere with endogenous corticosteroid production
|
0.19
|
|
corticosteroid
→
ReceivesAction
→
absorbed through the skin
|
0.19
|
|
corticosteroid
→
CapableOf
→
impair the ability of wounds
|
0.19
|
|
corticosteroid
→
HasProperty
→
strong
|
0.19
|
|
corticosteroid
→
ReceivesAction
→
used to reduce anticancer drugs
|
0.19
|
|
corticosteroid
→
ReceivesAction
→
used to deplete activated cells
|
0.19
|
|
corticosteroid
→
CapableOf
→
decrease the effectiveness of treatment
|
0.19
|
|
corticosteroid
→
Causes
→
glaucoma
|
0.18
|
|
corticosteroid
→
HasProperty
→
mutagenic
|
0.16
|
|
corticosteroid
→
CapableOf
→
cause mood swings
|
0.16
|
|
corticosteroid
→
CapableOf
→
produce false negative results
|
0.16
|
|
corticosteroid
→
CapableOf
→
suppress eosinophil
|
0.16
|
|
corticosteroid
→
CapableOf
→
alter the progression of copd
|
0.16
|
|
corticosteroid
→
ReceivesAction
→
associated with myocardial rupture
|
0.16
|
|
corticosteroid
→
ReceivesAction
→
administered for grade ≥ 2 events
|
0.16
|
|
corticosteroid
→
Causes
→
thrush
|
0.16
|
|
corticosteroid
→
HasProperty
→
life-saving
|
0.16
|
|
corticosteroid
→
CapableOf
→
prevent the body
|
0.16
|
|
corticosteroid
→
CapableOf
→
improve problem
|
0.16
|
|
corticosteroid
→
CapableOf
→
inhibit vascular endothelial growth factor
|
0.16
|
|
corticosteroid
→
CapableOf
→
reduce vascular permeability
|
0.16
|
|
administered corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
secreted into breast milk
|
0.16
|
|
inhaled corticosteroid
(subgroup of
corticosteroid)
→
ReceivesAction
→
used with caution
|
0.16
|
|
inhaled corticosteroid
(subgroup of
corticosteroid)
→
CapableOf
→
reduce airway inflammation
|
0.16
|
|
topical corticosteroid
(subgroup of
corticosteroid)
→
HasProperty
→
effective
|
0.16
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
common
|
0.16
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
associated with corticosteroid
|
0.16
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
seen in dog
|
0.16
|
|
effect
(aspect of
corticosteroid)
→
ReceivesAction
→
observed
|
0.14
|
|
effect
(aspect of
corticosteroid)
→
HasProperty
→
severe
|
0.03
|
|